<DOC>
	<DOCNO>NCT01618968</DOCNO>
	<brief_summary>Relative Bioavailability Comparison study</brief_summary>
	<brief_title>Comparison Methotrexate ( MTX ) VIBEX™ MTX Device</brief_title>
	<detailed_description>A Phase 2 , Open-Label , Randomized , 3-Way Crossover Study Compare Relative Bioavailability Oral Methotrexate VIBEX™ MTX Device Adult Subjects With Rheumatoid Arthritis</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Male female patient ≥18 year age , diagnose Rheumatoid Arthritis Pregnant females Any clinically significant disease disorder , opinion investigator might put subject risk</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>